Minerals is the big money earner at the moment but this will always be cyclical - but I think that the one to watch is the life sciences and food testing. Acquisitions a plenty throughout Europe on this front. So revenue will increase and this will stabilise the cyclical nature of minerals testing.
A lot of testing is ongoing and preventative also (at least in Industrial) so it's usually a constant stream of revenue.
Re the name change - ALS is the lions share of all the revenue . Campbell Brothers was the figurehead company but didn't produce anything - it was slightly confusing to the market.
CPB Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held
